Accretion Nutraveda Limited Board of Directors approved alterations to the Memorandum of Association and increased borrowing limits during a meeting held on September 1, 2026. The resolutions seek to expand operational scope and financial flexibility.

The approvals are subject to shareholder consent through a postal ballot process and compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the Postal Ballot Notice will be filed with stock exchanges and published on the company website.

Proposed Alterations to Memorandum of Association

The Board proposed altering Object Clause III of the MOA to broaden the company’s business activities. The changes involve inserting or substituting objects in Main Object Clause III(A) and adding new sub-clauses III(B)(58) to III(B)(69).

Expanded Main Objects

The revised main objects permit the company to engage in a wider range of healthcare and food-related activities:

• Manufacturing and trading nutraceuticals, dietary supplements, vitamins, Ayurvedic, Homeopathic, Unani, Allopathic, and herbal products.
• Dealing in pharmaceuticals, bulk drugs, intermediates, raw materials, and medical devices including diagnostic kits and surgical instruments.
• Establishing and operating hospitals, diagnostic centres, nursing homes, medical colleges, and research laboratories.
• Producing and distributing mineral waters, health foods, nutraceuticals, and consumer food items such as juices, pickles, energy drinks, and probiotic foods.
• Supporting sick funds and charitable organizations for providing medicines and healthcare products.

Additional Powers

The new sub-clauses grant powers necessary for furtherance of the main objects, including:

• Investing in shares, stocks, securities, bonds, and other financial instruments.
• Acquiring buildings, factories, machinery, and land for business operations.
• Conducting scientific and technical research through laboratories and workshops.
• Undertaking backward and forward integration, including contract farming and sourcing raw materials like herbs and botanical extracts.
• Cultivating agricultural produce and managing farms, orchards, and processing units.

Financial and Corporate Governance Approvals

The Board also approved several proposals related to financial flexibility and corporate governance under the Companies Act, 2013:

• Increasing borrowing limits under Section 180(1)(c) for raising loans, issuing debt securities, or debt instruments via private placement or public issue.
• Enhancing limits under Section 180(1)(a) for creating charges, mortgages, or hypothecation on movable and immovable properties in favour of banks and lenders.
• Advancing loans or providing guarantees to entities where directors may be interested, under Section 185.
• Granting loans, guarantees, and investments exceeding prescribed limits under Section 186.

These measures aim to strengthen the company’s capital structure and enable strategic investments while maintaining regulatory compliance.

Accretion Nutraveda Limited declared the voting results for its fifth annual general meeting held on August 27, 2026. Shareholders unanimously approved all ten resolutions proposed at the gathering.

The meeting, conducted via video conferencing, saw shareholders adopt the standalone financial statements for FY26 and approve key board changes. The scrutinizer report confirmed that all resolutions received 100% of the votes cast in their favor, with no votes against or invalid votes recorded.

Voting Results Overview

The remote e-voting facility was open from August 24 to August 26, 2026. Members who did not vote remotely were given a window to cast electronic votes during the meeting. Mr. Nimish Chunibhai Sakhya served as the scrutinizer for the process.

The consolidated results for the key resolutions are detailed below:

Board and Governance Updates

Shareholders approved the reappointment of Mr. Vivek Ashokkumar Patel as a director retiring by rotation. Additionally, the company secured approval for the appointment of two new independent directors: Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale.

The Board also obtained unanimous approval for revised remuneration packages for several key executives. These revisions covered:

• Mr. Mayur Popatlal Sojitra (Managing Director)
• Mr. Paraskumar Vinubhai Parmar (CFO and Director)
• Mr. Ankurkumar Shantilal Patel (Whole-Time Director)
• Mr. Harshad Nanubhai Rathod (Director)
• Mr. Vivek Ashokkumar Patel (Director)
• Mr. Hardik Mukundbhai Prajapati (Director)

Audit and Compliance

The statutory auditor, CA Dr. Vishves Shah, and secretarial auditor, Mr. Nimish Sakhija, were present at the meeting. The audit reports for the year ended March 31, 2026, contained no qualifications or adverse observations. Consequently, these reports were not read out during the meeting, adhering to standard procedural requirements under the Companies Act, 2013.

Mr. Harshad Rathod, Chairman and Director, presided over the proceedings, which commenced at 2:00 pm and concluded at 2:18 pm.